Vistagen Therapeutics, Inc. Quarterly Revenues in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Vistagen Therapeutics, Inc. quarterly/annual Revenues history and growth rate from Q2 2010 to Q1 2023.
  • Vistagen Therapeutics, Inc. Revenues for the quarter ending March 31, 2023 was $176K, a 351% increase year-over-year.
  • Vistagen Therapeutics, Inc. Revenues for the twelve months ending March 31, 2023 was -$227K, a 120% decline year-over-year.
  • Vistagen Therapeutics, Inc. annual Revenues for 2022 was -$227K, a 120% decline from 2021.
  • Vistagen Therapeutics, Inc. annual Revenues for 2021 was $1.11M, a 1.79% increase from 2020.
  • Vistagen Therapeutics, Inc. annual Revenues for 2020 was $1.09M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$227K $176K +$137K +351% Jan 1, 2023 Mar 31, 2023 10-K 2023-06-28
Q4 2022 -$364K $180K -$178K -49.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-06-28
Q3 2022 -$186K -$893K -$1.25M -349% Jul 1, 2022 Sep 30, 2022 10-K 2023-06-28
Q2 2022 $1.07M $310K -$44K -12.4% Apr 1, 2022 Jun 30, 2022 10-K 2023-06-28
Q1 2022 $1.11M $39K -$403K -91.2% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-28
Q4 2021 $1.51M $358K +$44K +14% Oct 1, 2021 Dec 31, 2021 10-K 2023-06-28
Q3 2021 $1.47M $358K +$24K +7.19% Jul 1, 2021 Sep 30, 2021 10-K 2023-06-28
Q2 2021 $1.44M $354K +$354K Apr 1, 2021 Jun 30, 2021 10-K 2023-06-28
Q1 2021 $1.09M $442K +$442K Jan 1, 2021 Mar 31, 2021 10-K 2021-06-29
Q4 2020 $648K $314K +$314K Oct 1, 2020 Dec 31, 2020 10-K 2021-06-29
Q3 2020 $334K $334K +$334K Jul 1, 2020 Sep 30, 2020 10-K 2021-06-29
Q2 2020 $0 $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $0 $0 Jan 1, 2020 Mar 31, 2020 10-K 2021-06-29
Q4 2019 $0 Oct 1, 2019 Dec 31, 2019 10-K 2021-06-29
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-K 2021-06-29
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-K 2021-06-29
Q4 2017 $0 -$1.25M -100% Oct 1, 2017 Dec 31, 2017 10-Q 2018-02-12
Q1 2017 $1.25M $0 Jan 1, 2017 Mar 31, 2017 10-K 2018-06-26
Q4 2016 $1.25M +$1.25M Oct 1, 2016 Dec 31, 2016 10-K 2018-06-26
Q3 2016 $0 Jul 1, 2016 Sep 30, 2016 10-K 2018-06-26
Q2 2016 $0 Apr 1, 2016 Jun 30, 2016 10-K 2018-06-26
Q4 2015 $0 Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-13
Q2 2012 $987K $200K -$355K -63.9% Apr 1, 2012 Jun 30, 2012 10-K 2014-06-25
Q1 2012 $1.34M $469K +$116K +33% Jan 1, 2012 Mar 31, 2012 10-K 2013-07-18
Q4 2011 $1.23M $2K -$583K -99.7% Oct 1, 2011 Dec 31, 2011 10-K 2013-07-18
Q3 2011 $1.81M $316K -$83.6K -20.9% Jul 1, 2011 Sep 30, 2011 10-K 2013-07-18
Q2 2011 $1.89M $555K -$179K -24.4% Apr 1, 2011 Jun 30, 2011 10-K 2013-07-18
Q1 2011 $2.07M $353K Jan 1, 2011 Mar 31, 2011 10-K 2012-07-02
Q4 2010 $585K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 $400K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $734K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.